(PharmaNewsWire.Com, March 23, 2018 ) The market is showcasing evident potential in the mentioned forecasting period. The antinuclear antibody test is a primary test to check a person’s autoimmune disorders. Autoimmune disorders can affect many tissues and organs in the body. This test is most often used to diagnose the Systemic Lupus Erythematosus (SLE) and Rheumatoid Arthritis.
Antinuclear Antibody Test Market Drivers and Restraints: Factors such as an increase in the prevalence of autoimmune diseases, such as rheumatoid arthritis and SLE, and growth in the awareness of people about these diseases, are driving this market. Autoimmune diseases can also cause type I diabetes. According to WHO, from 1980 to 2014 number of people suffering from diabetes has increased from 108 million to 422 million and is expected to grow at the same rate in near future. Other factors such as, increase in healthcare expenditure of people due to growing economies, and government healthcare insurance & reimbursement policies are fuelling this market. On the other hand, factors such as diagnostic errors, product approval, and unavailability of skilled labor are hindering the growth of this market.
Antinuclear Antibody Test Market Segment: The Market is broadly categorized on the basis of Disease, Technique, Product, and End-Users. On the basis of Disease, it is further sub-categorized into Systemic Lupus Erythematosus (SLE) and Rheumatoid Arthritis. On the basis of Technique, it is segmented into Immunofluorescence, Multiplex, and ELISA. On the basis of Product, it is divided into Software, Systems, Services, and Reagents & Assay Kits. It is divided into Hospitals, and Clinical Labs on the basis of End-Users. As of 2016, Assay Kits & reagents segment accounts for the largest share of global ANA testing market. It can be because of the growth in a number of reagent rental agreements. On the basis of Diseases, Rheumatoid Arthritis is expected to have the largest share in the market until the end of the forecast period due to the increased incidences of rheumatoid arthritis. ELISA is currently leading the market on the basis of the technique used for testing.
Market Geographical Analysis:
Geographically, the Antinuclear Antibody Test Market is segmented into North America, Latin America, Europe, Middle East & Africa, and Asia-Pacific. Of all these regions, North America has the biggest market share mainly because of growing population and healthcare spending, and growth of people under medical insurances in the U.S. Asia-Pacific is growing at the fastest rate in this market in terms of CAGR.
Antinuclear Antibody Test Industry Key Players: Some of the major companies dominating the market, by their products and services include Zeus Scientific Inc., Inova Diagnostics, Immuno Concepts, Euroimmun AG, Antibodies Inc., Thermo Fisher Scientific inc., Trinity Biotech plc, ERBA Diagnostics Inc., Bio-Rad Laboratories Inc., and Alere Inc.
About Us: Market Data Forecast is a firm working in the area of market research and business intelligence. With rich experience in research across various business domains, we cater to the needs of both individual and corporate clients. Our analyst team comprises expert professionals in market research, who with their collective knowledge and skillsets dedicatedly serve clients from various industries and regions.
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Biotechnology & Pharmaceuticals resource center today to browse our selection of 600+ complimentary Biotechnology & Pharmaceuticals magazines, white papers, webinars, podcasts, and more. Get popular titles including:
